| [1] |
Cortese S, Song M, Farhat LC, et al. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study[J]. Mol Psychiatry, 2023, 28(11): 4823-4830. DOI: 10.1038/s41380-023-02228-3.
|
| [2] |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR[M]. 5th ed. Washington, DC: American Psychiatric Association Publishing, 2022. DOI: 10.1176/appi.books.9780890425787.
|
| [3] |
Kang J, Lee H, Kim S, et al. Comorbid health conditions in people with attention-deficit/hyperactivity disorders: an umbrella review of systematic reviews and Meta-analyses[J]. Asian J Psychiatr, 2024, 99: 104135. DOI: 10.1016/j.ajp.2024.104135.
|
| [4] |
Weiss MD. A paradigm for targeting functional impairment as an outcome in attention-deficit/hyperactivity disorder[J]. Brain Sci, 2022, 12(8): 1014. DOI: 10.3390/brainsci12081014.
|
| [5] |
|
| [6] |
Wanni Arachchige Dona S, Badloe N, Sciberras E, et al. The impact of childhood attention-deficit/hyperactivity disorder on children′s health-related quality of life: a systematic review and Meta-analysis[J]. J Atten Disord, 2023, 27(6): 598-611. DOI: 10.1177/10870547231155438.
|
| [7] |
Weiss MD, McBride NM, Craig S, et al. Conceptual review of measuring functional impairment: findings from the Weiss functional impairment rating scale[J]. Evid Based Ment Health, 2018, 21(4): 155-164. DOI: 10.1136/ebmental-2018-300025.
|
| [8] |
French B, Nalbant G, Wright H, et al. The impacts associated with having ADHD: an umbrella review[J]. Front Psychiatry, 2024, 15: 1343314. DOI: 10.3389/fpsyt.2024.1343314.
|
| [9] |
Haack LM, Gerdes AC, Lawton KE, et al. Understanding and measuring functional impairment in diverse children with ADHD: development of the ADHD-FX scale with an at-risk, community sample[J]. J Atten Disord, 2016, 20(6): 487-500. DOI: 10.1177/1087054714527791.
|
| [10] |
Haack LM, Gonring K, Harris M, et al. Assessing impairment in childhood ADHD: validation of the parent and teacher ADHD-FX rating scale in a dual-site clinical sample[J]. J Atten Disord, 2019, 23(6): 541-552. DOI: 10.1177/1087054716659360.
|
| [11] |
Haack LM, Gerdes AC. Culturally appropriate assessment of functional impairment in diverse children: validation of the ADHD-FX scale with an at-risk community sample[J]. J Atten Disord, 2017, 21(11): 913-920. DOI: 10.1177/1087054714553021.
|
| [12] |
Barkley RA. Barkley functional impairment scale: children and adolescents (BFIS-CA)[M]. New York: Guilford Press, 2012.
|
| [13] |
Mcgill RJ. Assessing psychosocial impairment in children and adolescents: a review of the Barkley functional impairment scale (BFIS)[J]. Contemp School Psychol, 2014, 18(4): 255-260. DOI: 10.1007/s40688-014-0022-2.
|
| [14] |
Fabiano GA, Pelham WE Jr, Waschbusch DA, et al. A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples[J]. J Clin Child Adolesc Psychol, 2006, 35(3): 369-385. DOI: 10.1207/s15374424jccp3503_3.
|
| [15] |
|
| [16] |
Schoeman R, Lai EY, Nel AM, et al. Safety and effectiveness of methylphenidate ER multi-unit pellet system in ADHD patients: an open label study[J]. S Afr J Psychiatr, 2024, 30: 2267. DOI: 10.4102/sajpsychiatry.v30i0.2267.
|
| [17] |
Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder[J]. Neurosci Biobehav Rev, 2021, 128: 789-818. DOI: 10.1016/j.neubiorev.2021.01.022.
|
| [18] |
Knyazhansky M, Shrot T. ADHD diagnostic tools across ages: traditional and digital approaches[J]. Front Psychiatry, 2025, 16: 1668070. DOI: 10.3389/fpsyt.2025.1668070.
|
| [19] |
Torous J, Bucci S, Bell IH, et al. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality[J]. World Psychiatry, 2021, 20(3): 318-335. DOI: 10.1002/wps.20883.
|